TR200000988T2 - Bakteri kolonizasyonunun kontrol edilmesi için bileşimler - Google Patents

Bakteri kolonizasyonunun kontrol edilmesi için bileşimler

Info

Publication number
TR200000988T2
TR200000988T2 TR2000/00988T TR200000988T TR200000988T2 TR 200000988 T2 TR200000988 T2 TR 200000988T2 TR 2000/00988 T TR2000/00988 T TR 2000/00988T TR 200000988 T TR200000988 T TR 200000988T TR 200000988 T2 TR200000988 T2 TR 200000988T2
Authority
TR
Turkey
Prior art keywords
enzyme
anchor
bacterial
compositions
complex
Prior art date
Application number
TR2000/00988T
Other languages
English (en)
Inventor
A. Budny John
Original Assignee
Pharmacal Biotechnologies Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacal Biotechnologies Inc. filed Critical Pharmacal Biotechnologies Inc.
Publication of TR200000988T2 publication Critical patent/TR200000988T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Bakteri büyümesi/kolonizasyonunun kontrol edilmesi için bir bilesim temin edilmistir. Bilesim, bir enzimi, bir enzim-ankor kompleksini olusturmak üzere enzime baglanmis bir ankor molekülünü içermektedir, ankor, bir bakteri kolonisine yakin bir alt-tabakaya baglanabilmektedir. Alt-tabakaya baglanma, bakteri kolonisinin kompleksin etkililigini arttirmak üzere mevcut oldugu kisimda, enzim-ankor kompleksinin tutulma süresini uzatmaktadir. Bulus, ayni zamanda, agiz boslugunda bakteri plakinin kolonizasyonunun kontrol edilmesi için bir yöntem olmanin yanisira, agiz boslugu içinde bakteri kolonilerinin çogalmasinin kontrol edilmesi için bir bilesimin olusturulmasi için bir yöntemdir.
TR2000/00988T 1997-10-16 1998-10-13 Bakteri kolonizasyonunun kontrol edilmesi için bileşimler TR200000988T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/951,393 US5871714A (en) 1997-10-16 1997-10-16 Compositions for controlling bacterial colonization

Publications (1)

Publication Number Publication Date
TR200000988T2 true TR200000988T2 (tr) 2000-08-21

Family

ID=25491643

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00988T TR200000988T2 (tr) 1997-10-16 1998-10-13 Bakteri kolonizasyonunun kontrol edilmesi için bileşimler

Country Status (22)

Country Link
US (1) US5871714A (tr)
EP (1) EP1023084A1 (tr)
JP (1) JP2001519404A (tr)
KR (1) KR20010015757A (tr)
CN (1) CN1276732A (tr)
AU (1) AU742762B2 (tr)
BR (1) BR9812923A (tr)
CA (1) CA2306459A1 (tr)
CU (1) CU22838A3 (tr)
CZ (1) CZ20001237A3 (tr)
EA (1) EA002244B1 (tr)
HU (1) HUP0100016A2 (tr)
ID (1) ID24368A (tr)
IL (1) IL135628A0 (tr)
IN (1) IN2002DE00891A (tr)
MX (1) MXPA00003618A (tr)
NO (1) NO20001885L (tr)
NZ (1) NZ503974A (tr)
PL (1) PL339900A1 (tr)
TR (1) TR200000988T2 (tr)
WO (1) WO1999018999A1 (tr)
ZA (1) ZA989024B (tr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6830745B1 (en) * 1997-10-16 2004-12-14 Pharmacal Biotechnologies, Llc Compositions for treating biofilm
US6159447A (en) * 1997-10-16 2000-12-12 Pharmacal Biotechnologies, Llc Compositions for controlling bacterial colonization
US20020022005A1 (en) * 1997-10-16 2002-02-21 Budny John A. Compositions for treating cystic fibrosis
US5972311A (en) * 1998-01-26 1999-10-26 Duke University Method of preventing dental caries and other oral lesions
DE19909770A1 (de) 1999-03-05 2000-09-07 Werner Lubitz Bakterienghosts als Träger- und Targetingvehikel
US8522127B2 (en) 2001-07-16 2013-08-27 Robert G. Adamson, III Allowing operating system access to non-standard fonts in a network document
US10810355B1 (en) 2001-07-16 2020-10-20 Clantech, Inc. Allowing operating system access to non-standard fonts in a network document
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
CA2585017A1 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides
EP2099466B1 (en) * 2006-12-01 2015-06-03 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
JP5628031B2 (ja) 2007-07-25 2014-11-19 スリーエム イノベイティブ プロパティズ カンパニー 治療用歯科用組成物及び関連する方法
JP5453260B2 (ja) * 2007-07-25 2014-03-26 スリーエム イノベイティブ プロパティズ カンパニー 被膜形成歯科用組成物及び関連する方法
EP2092834A1 (en) * 2008-02-19 2009-08-26 Innopact B.V. Methods and compositions of sphingolipid for preventing treating microbial infections
WO2012087966A2 (en) 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Targeted perhydrolases
BR112013015459B8 (pt) 2010-12-20 2018-06-12 Du Pont método, produto de cuidado oral e composição de geração de perácido
CN102219597B (zh) * 2011-04-11 2013-09-11 北京中农瑞利源高科技发展有限公司 酶控剂和酶控系列肥料及其在农业中的应用
US20120315260A1 (en) * 2011-06-13 2012-12-13 Svetlana A. Ivanova Compositions and Methods to Prevent and Treat Biofilms
US10420822B2 (en) 2011-06-13 2019-09-24 Ziolase, Llc Compositions and methods to prevent and treat biofilms
US9763881B2 (en) 2012-06-11 2017-09-19 Council Of Scientific And Industrial Research Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
KR102360720B1 (ko) * 2015-06-30 2022-02-10 (주)아모레퍼시픽 프라그 기질 용해제
CN111551416B (zh) * 2020-03-22 2021-08-06 华南理工大学 一种基于细胞膜磷脂酰丝氨酸荧光染色的细菌类凋亡评价方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1373487A (en) * 1970-10-26 1974-11-13 Guggenheim B Enzymes their preparation and uses
US4335101A (en) * 1971-08-10 1982-06-15 Merck & Co., Inc. Oral hygiene enzymes and method for preparation
JPS5536317B2 (tr) * 1972-04-22 1980-09-19
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
US4138476A (en) * 1977-08-03 1979-02-06 The United States Of America As Represented By The Secretary Of The Navy Plaque dispersing enzymes as oral therapeutic agents by molecular alteration
JPS57165312A (en) * 1981-04-03 1982-10-12 Handai Biseibutsubiyou Kenkyukai Production of oral composition
JPH0641424B2 (ja) * 1984-11-06 1994-06-01 ライオン株式会社 う蝕予防剤
US5306639A (en) * 1985-03-20 1994-04-26 Aizo Matsushiro DNA encoding glucanase enzymes
US4737359A (en) * 1985-04-18 1988-04-12 Colgate-Palmolive Company Control of dental plaque and caries using emulsan
GB8528761D0 (en) * 1985-11-22 1985-12-24 Axon Healthcare Ltd Enzyme-coupled antibodies
WO1991000112A1 (en) * 1989-06-30 1991-01-10 Brunswick Corporation Antibody-lactate oxidase conjugates
JPH0363215A (ja) * 1989-07-29 1991-03-19 Nakano Vinegar Co Ltd 歯垢分解組成物
AU642980B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Ultilization of enzymes
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US5320831A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5490978A (en) * 1993-10-15 1996-02-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Block copolymers of polysaccharides and polyalkylene oxides
EP0824019B1 (en) * 1996-08-13 2002-11-20 Quest International B.V. Inhibition or reduction of oral malodour

Also Published As

Publication number Publication date
ID24368A (id) 2000-07-13
BR9812923A (pt) 2000-08-08
IL135628A0 (en) 2001-05-20
US5871714A (en) 1999-02-16
NZ503974A (en) 2002-05-31
HUP0100016A2 (hu) 2001-05-28
PL339900A1 (en) 2001-01-15
ZA989024B (en) 1999-04-07
AU9802898A (en) 1999-05-03
EA002244B1 (ru) 2002-02-28
NO20001885L (no) 2000-06-14
AU742762B2 (en) 2002-01-10
CA2306459A1 (en) 1999-04-22
KR20010015757A (ko) 2001-02-26
CU22838A3 (es) 2006-04-18
NO20001885D0 (no) 2000-04-12
CZ20001237A3 (cs) 2000-08-16
IN2002DE00891A (tr) 2005-01-21
CN1276732A (zh) 2000-12-13
WO1999018999A1 (en) 1999-04-22
EP1023084A1 (en) 2000-08-02
JP2001519404A (ja) 2001-10-23
EA200000422A1 (ru) 2000-10-30
MXPA00003618A (es) 2001-10-01

Similar Documents

Publication Publication Date Title
EA200000422A1 (ru) Композиция для управления образованием бактериальных колоний
MXPA02012326A (es) Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso.
ATE300272T1 (de) Verwendung von zahnprothesenhaftmitteln zur zahnsteinbildungskontrolle
IL121895A (en) Slow release composition for oral consumption containing a zinc compound an amino acid and copper compound
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
GEP20022617B (en) 3-Heterocyclic YL-Substituted Benzoyl Derivatives, Method for Their Production, Herbicidal Preparation and Method for Undesirable Plants Control
UA41275C2 (uk) Гербіцидна композиція та спосіб контролю росту небажаних рослин
DE60332101D1 (de) Antimikrobielle zusammensetzung
ATE331496T1 (de) Zahnprothesenhaftmittel mit zahnsteinbildungskontrolle
EP0743311A4 (en) FLAVANONOL DERIVATIVES AND COMPOSITION CONTAINING SUCH DERIVATIVES SUITABLE FOR FEEDING HAIR AND STIMULATING THEIR GROWTH
BR0317520A (pt) Composições de inibidores de proteìna de transferência de ésteres de colesterilo e inibidores de hmg-coa redutase
PT999750E (pt) Composicao antifungica
DE60334846D1 (de) VERWENDUNG von LIGNINPEROXIDASE ZUR HAUT- UND HAARAUFHELLUNG
NZ502239A (en) Synergistic antimicrobial compositions containing a dimethylamide of a carboxylic acid with a mixture of 2-(thiocyanomethylthio) benzothiazole and methylene-bis(thiocyanate)
EP0469040A4 (en) HYGIENIC TOOTH COMPOSITION TO REDUCE PERIODONTAL DISEASES.
EP1503798B8 (en) Stabilised solid compositions of modified factor vii
MXPA04001248A (es) Reduccion del crecimiento del vello.
GR3032698T3 (en) Organic compounds
SI1525188T1 (sl) Novi derivati 4,4-ditiobis-(3-aminobutan-1-sulfonatov) in sestavki, ki jih vsebujejo
ATE185682T1 (de) Für die vermeidung/begrenzung von mikrobiologisch beeinflusster korrosion und verfärbung verwendbare borate
GR980100040A (el) Ζιζανιοκτονος συνεργικη συνθεση και μεθοδος ελεγχου ζιζανιων
EP1088896A3 (en) Chromogenic media containing blood or hemin
EP1133991A4 (en) BACTERIOSTATIC COMPOSITIONS AGAINST SALMONELLA
MX9605346A (es) Compuesto antimicrobianos con velocidad rapida de eliminacion.
FI940917L (fi) Menetelmä ja koostumus mikro-organismien kasvun kontrolloimiseksi